PCSK9 and stroke disorder: For these patients, intensive management of the intracranial significant stenosis caused by atherosclerosis, e.g., high-intensity statins, the proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitor, or even endovascular therapy, may be beneficial for the post-stroke functional recovery.